Eva Fortea Verdejo

Stock Analyst at Wells Fargo

(4.41)
# 342
Out of 5,139 analysts
22
Total ratings
56.25%
Success rate
42.02%
Average return

Stocks Rated by Eva Fortea Verdejo

Relay Therapeutics
Dec 12, 2025
Upgrades: Overweight
Price Target: $6$13
Current: $7.35
Upside: +76.87%
Zymeworks
Dec 12, 2025
Upgrades: Overweight
Price Target: $25$33
Current: $23.47
Upside: +40.61%
Bicara Therapeutics
Nov 11, 2025
Maintains: Equal-Weight
Price Target: $8$11
Current: $16.75
Upside: -34.33%
Immunocore Holdings
Oct 31, 2025
Initiates: Overweight
Price Target: $60
Current: $33.35
Upside: +79.91%
Arcus Biosciences
Oct 20, 2025
Maintains: Overweight
Price Target: $25$29
Current: $21.80
Upside: +33.03%
Kiniksa Pharmaceuticals International,
Sep 25, 2025
Maintains: Overweight
Price Target: $42$45
Current: $39.41
Upside: +14.18%
Revolution Medicines
Sep 11, 2025
Maintains: Overweight
Price Target: $67$70
Current: $120.28
Upside: -41.80%
Xencor
Aug 7, 2025
Maintains: Overweight
Price Target: $33$27
Current: $12.79
Upside: +111.10%
IDEAYA Biosciences
Jun 26, 2025
Initiates: Overweight
Price Target: $44
Current: $35.84
Upside: +22.77%